环丙沙星：概述与前瞻性评估。 - Suppr

Suppr

超能文献

Ciprofloxacin: an overview and prospective appraisal.

作者信息

Neu H C

出版信息

Am J Med. 1987 Apr 27;82(4A):395-404.

PMID:3578329

Abstract

摘要

相似文献

Ciprofloxacin: an overview and prospective appraisal.环丙沙星：概述与前瞻性评估。

Am J Med. 1987 Apr 27;82(4A):395-404.

Treatment of common infectious disorders.

W V Med J. 1976 Jun;72(6):135-45.

Ciprofloxacin: an update on clinical experience.环丙沙星：临床经验最新进展

Am J Med. 1987 Apr 27;82(4A):381-6.

[Rational and economic antibiotics therapy in medical practice and outpatient clinics].

Dtsch Med Wochenschr. 1984 May 25;109(21):834-40. doi: 10.1055/s-2008-1069284.

Ciprofloxacin: an oral quinolone for the treatment of infections with gram-negative pathogens. Committee on Antimicrobial Agents. Canadian Infectious Disease Society.环丙沙星：一种用于治疗革兰氏阴性病原体感染的口服喹诺酮类药物。抗菌药物委员会。加拿大传染病协会。

CMAJ. 1994 Mar 1;150(5):669-76.

Prescribing considerations in fluoroquinolone therapy.氟喹诺酮类药物治疗中的处方考量

Pharmacotherapy. 1993 Mar-Apr;13(2 Pt 2):39S-44S.

Efficacy, safety, and potential economic benefits of oral ciprofloxacin in the treatment of infections.口服环丙沙星治疗感染的疗效、安全性及潜在经济效益。

Rev Infect Dis. 1988 May-Jun;10(3):528-43. doi: 10.1093/clinids/10.3.528.

[Oral ciprofloxacin therapy in juvenile patients with cystic fibrosis--results of a prospective pilot study].[环丙沙星口服治疗囊性纤维化青少年患者——一项前瞻性初步研究的结果]

Kinderarztl Prax. 1993 Aug;61(6):211-4.

The role of the fluoroquinolones in primary care practice.氟喹诺酮类药物在基层医疗实践中的作用。

Clin Invest Med. 1989 Feb;12(1):71-3.

Cephalexin: a review of its antibacterial, pharmacological and therapeutic properties.头孢氨苄：对其抗菌、药理和治疗特性的综述。

Drugs. 1972;3(1):9-78. doi: 10.2165/00003495-197203010-00002.

引用本文的文献

Mechanistic insight of cell anti-proliferative activity of fluoroquinolone drug-based Cu(II) complexes.基于氟喹诺酮药物的 Cu(II) 配合物对细胞抗增殖活性的作用机制研究。

Mol Divers. 2022 Apr;26(2):869-878. doi: 10.1007/s11030-021-10199-2. Epub 2021 Mar 1.

Risk factors associated with fluoroquinolone-resistant enterococcal urinary tract infections in a tertiary care university hospital in north India.印度北部一家三级护理大学医院中与耐氟喹诺酮肠球菌尿路感染相关的危险因素。

Indian J Med Res. 2016 Oct;144(4):604-610. doi: 10.4103/0971-5916.200897.

1-Cyclo-propyl-6-fluoro-7-(4-nitro-so-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid.

Acta Crystallogr Sect E Struct Rep Online. 2009 Jul 31;65(Pt 8):o2053. doi: 10.1107/S1600536809029729.

Modeling antibiotic resistance to project future rates: quinolone resistance in Escherichia coli.建立抗生素耐药性模型以预测未来的耐药率：大肠杆菌中的喹诺酮类耐药性。

Eur J Clin Microbiol Infect Dis. 2010 Mar;29(3):353-6. doi: 10.1007/s10096-009-0862-x. Epub 2010 Jan 30.

Growth in the presence of salicylate increases fluoroquinolone resistance in Staphylococcus aureus.在水杨酸盐存在的情况下生长会增加金黄色葡萄球菌对氟喹诺酮类药物的耐药性。

Antimicrob Agents Chemother. 1999 Apr;43(4):990-2. doi: 10.1128/AAC.43.4.990.

In vivo efficacy of trovafloxacin (CP-99,219), a new quinolone with extended activities against gram-positive pathogens, Streptococcus pneumoniae, and Bacteroides fragilis.曲伐沙星（CP-99,219）的体内疗效，一种对革兰氏阳性病原体、肺炎链球菌和脆弱拟杆菌具有广泛活性的新型喹诺酮类药物。

Antimicrob Agents Chemother. 1995 Oct;39(10):2210-6. doi: 10.1128/AAC.39.10.2210.

CMAJ. 1994 Mar 1;150(5):669-76.

Bacterial resistance to fluoroquinolones: lessons to be learned.细菌对氟喹诺酮类药物的耐药性：应吸取的教训。

Infection. 1994;22 Suppl 2:S140-7. doi: 10.1007/BF01793579.

Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星：抗菌活性、药代动力学特性及治疗用途综述

Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.

Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。

Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验